ARCHIVES

FDA Committee Approves Two NDAs, Blocks One, Hears NCI Toxicology Plan

This article is from The Cancer Letter archive.

Vol. 05 No. 24 | June 15, 1979

Download PDF Visit The Full Archive

Related Articles

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

In Brief: BRCA 2 Gene sequence Published; CALGB To Mark 40th Anniversary

March 8, 1996

In Brief: Lombardi Comprehensive Designation Renewed; Yale Plans Breast Cancer Lab

September 26, 1997

Severe Shortages Of Many Cancer Drugs Affecting Practices

November 19, 2010

FDA Moves to Regulate Lab-Developed Tests

August 1, 2014

In Brief: Painter Is AMA President-Elect; FDA Approves Taxol; Protocol Enrolls 150-200 A Month

August 14, 1992